Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "and will thus have a direct impact on the market price going forward."

"and will thus have a direct impact on the market price going forward."

posted on Sep 16, 2009 10:57PM

"Mike Davis, Senior Vice President of Licensing at Alliacense, added :"These developments obviously diminish any uncertainties associated with purchasing the required MMP Portfolio license, and will thus have a direct impact on the market price going forward."

I like that they were willing to state it so. Aggressive language to be sure, but armed with the recert and the Markman, no excuse not to deliver on it now. Crank up the licensing machine, and while there should be no discounts, I think it's less important to bleed every last cent from a "willing" licensee, than it is to get higher dollar licenses and ongoing royalty licenses signed somewhat quickly to create the momentum, and to create the pressure for signers to sign so as to have a leg up on their competitors.

Share
New Message
Please login to post a reply